Search Results

GPCRs in Cardiology, Endocrinology, and Taste Gender Differences in GRK2 in Cardiovascular Diseases and Manager Director of Molecular Pharmacology, Discovery Biology Staff Scientist/Senior Staff Scientist, Disease

cellulose-degrading enzymes Functional Water Channels Within the TSH Receptor - a new paradigm for TSH action with disease launch LAB eN², a translational drug discovery accelerator, to address innovation gap in cardiometabolic diseases

disaccharide sugar with known pro‐autophagy activity and effective in alleviating diverse inflammatory diseases

intracellular protein complexes and solute carriers, are relevant to immunology indications and rare diseases

protein-coupled A2A adenosine receptor (A2AAR) have been considered promising agents to treat Parkinson's disease

Neisseria meningitidis is a Gram-negative opportunistic pathogen that is responsible for causing human diseases

conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs (G protein-coupled receptors) in disease-relevant

knockdown regulates the expression and alternative splicing of genes associated with aphasia-related diseases ochraceus quorum sensing through the GprC-AcyA pathway Deciphering the genetic landscape of lumpy skin disease

with the fact that dysregulation of compartmentalized GPCR signaling has been implicated in various diseases aberrant endosomal signaling by GPCRs has been linked to disorders such as cancer, neurodegenerative diseases Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases

macrophages and monocytes, and play a critical role in neuroinflammatory conditions such as Alzheimer's disease

numerous GPCRs have been studied for their impact on pathologic conditions, including cardiovascular diseases

Molecular Endocrinology and Pharmacology Laboratory team who are investigating new ways to tackle the disease-inducing

Portal Venous Blood as a Possible Mechanism for Microbiota Effects on the Immune System, and Western Diseases concept to metabolomics: New insights into pregnenolone function Molecular characterization of lumpy skin disease

Several S1PR therapeutic drugs have been developed to treat these diseases; however, they lack receptor

Retinitis pigmentosa (RP) is a group of hereditary degenerative diseases affecting 1 of 4000 people worldwide

Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's and Parkinson's diseases as druggable targets through Withania somnifera bioactives: an in silico study

effects of CB2 receptor activation, make this receptor an intriguing target for treating schizophrenia, a disease

determines the potential of a GPCR for arrestin-biased agonism The roles of RGS proteins in cardiometabolic disease Receptor Responses to Sequential Injections of Pure and Mixed Sweeteners GPCRs involved in metabolic diseases

(GPCR) targets with a goal of creating new drug discovery programs in the area of gastrointestinal diseases

understanding the modulatory role of the membrane environment on the organization and dynamics of GPCRs in diseases

plant-like” behavior in important human cell regulator, opening up a new drug target for cancer, other diseases Neuroscience Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease

/3 APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease transport by CCHCR1 via direct interaction Industry News Novartis Lutathera® significantly reduced risk of disease

phases of clinical development, and across multiple therapeutic areas, including Oncology, Infectious Diseases

including expensive cost of reagents, optimizing sensor expression levels and adapting these systems to disease-relevant the development of the BERKY and the ONE-GO biosensors, designed to facilitate their application in disease

protein-coupled receptors (aGPCRs) are keys of many physiological events and attractive targets for various diseases

fluorescent GPCR ligands "G-protein coupled receptors (GPCRs) have been largely targeted in a wide range of diseases

The mGlu5 receptor is a promising target for the treatment of psychiatric and neurodegenerative diseases

Founder & CEO, and Zach Jonasson, CFO & CBO at Absci Octant: A Next Generation Approach to Genetic Disease allosteric communication networks GPTrans: A Biological Language Model-Based Approach for Predicting Disease-Associated